Viewing nowCombinationSeviduo Tablets 5/20 mg
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201404821 · Approved 2014.10.21 · Insurance code 645404280
Treatment of essential hypertension not controlled by monotherapy
This medication helps provide additional blood pressure control for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or olmesartan medoxomil. It plays a crucial role in reducing the risk of cardiovascular complications and is effective for hypertension treatment. It supports patients' blood pressure management to contribute to maintaining a healthy lifestyle. Therefore, this medication is used for the treatment of essential hypertension.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended that the medication be taken at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or olmesartan medoxomil) be adjusted before starting this medication. However, switching directly to this medication may be considered if blood pressure is not controlled with monotherapy with an individual component. The maximum dose of this medication is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The recommended doses are as follows. - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams monotherapy. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams monotherapy. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ∘Patients with renal impairment: This medication has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily, and use of this medication is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ∘Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. ∘Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics, blood pressure and renal function should be closely monitored. This medication should not be administered to patients with severe hepatic impairment. (See section 2. Patients in whom this medication must not be administered under Precautions for Use.) ∘Elderly patients: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients.
∘Children: The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any components of this medication, severe liver impairment, aortic stenosis, biliary obstruction, those on renal dialysis, in shock, or certain diabetes patients should not take this medication. Patients with a lack of bodily fluids or salts may experience hypotension, so their condition should be closely monitored at the beginning of treatment. Patients with aortic stenosis should be particularly cautious due to the risk of sudden blood vessel dilation and hypotension. Patients with severe heart diseases should use this medication with caution as it may increase the risk of angina or myocardial infarction. Patients with compromised renal function may experience worsening renal function due to this medication, thus requiring careful monitoring. Patients with liver impairment may have prolonged exposure to the medication in their bodies, necessitating dosage adjustment and observation. Side effects such as dizziness, headaches, hypotension, edema, dyspepsia may occur; severe symptoms should prompt consultation with a physician. This medication should not be used during pregnancy, and nursing mothers should consult their doctor before taking it, as the drug may pass into breast milk and affect the infant. Children under 18 years should not use this medication due to lack of established safety and efficacy. Elderly patients may have reduced liver, kidney, or heart function, should start at low doses, and their condition should be closely observed. In case of overdose, severe hypotension and vasodilation may occur, requiring immediate medical assistance and continuous monitoring of blood pressure and heart function. This medication should be stored away from direct sunlight and moisture, out of reach of children. This medication can interact with other antihypertensive medications, so any other medications being taken must be disclosed, and caution should be taken as grapefruit juice may increase blood pressure-lowering effects.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best to store the medication at room temperature, between 1 degree and 30 degrees Celsius, avoiding excessively hot or cold conditions.
White round film-coated tablets
Alu-Alu - 30 tablets/Alu-Alu[(10 tablets/Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.